Where Can a Chicago-Area Clinician Refer a Client for qEEG Brain Mapping and Neurofeedback?

Direct Answer

Look for a service where a clinician holds board certification in neurofeedback from the Biofeedback Certification International Alliance, where a licensed clinician rather than a technician interprets the qEEG and sets the protocol and where the cost conversation happens before the first appointment. Those three filters remove most of the variability in this field, which is less regulated than transcranial magnetic stimulation and far more variable in training and practice.

Set expectations on two points before referring. qEEG is used to guide protocol selection, not to diagnose a psychiatric condition, and professional and payer positions both treat it as investigational for psychiatric indications. That means most psychiatric qEEG and neurofeedback referrals are self-pay, and a client should hear the likely cost from you rather than discovering it at intake. The neurofeedback evidence base is real but specific, strongest in ADHD and clearest when compared against non-active controls.

What qEEG Is, and What It Is Not

Quantitative EEG applies computerized analysis to EEG recordings and compares the result against normative databases, producing the maps that give brain mapping its name. In neurofeedback practice it is used to identify patterns that inform which protocol to train, which is a reasonable use of a measurement tool.

It is not established as a stand-alone diagnostic test for psychiatric conditions, and both the professional and the payer positions treat it that way. The joint American Academy of Neurology and American Clinical Neurophysiology Society assessment concluded that qEEG remains investigational for clinical use in attention disorders, schizophrenia, depression, learning disability, postconcussion syndrome and substance use, and aligned itself with an American Psychiatric Association task force finding that qEEG is not yet able to help in diagnosing conditions such as schizophrenia or depression.¹ That statement dates from 1997 and has been contested in the literature since, so it should be read as a long-standing position rather than a recent verdict.

The payer position is current and reaches the same practical conclusion. Aetna’s clinical policy bulletin on quantitative EEG, last reviewed in April 2026, covers qEEG only as an adjunct to traditional EEG for a defined set of neurological purposes, and deems it experimental and investigational for psychiatric conditions including ADHD, depression, anxiety, schizophrenia, bipolar disorder, obsessive compulsive disorder and post-traumatic stress disorder, citing inadequate evidence of clinical usefulness.² Other plans differ in detail, and the direction of travel is consistent.

The Neurofeedback Evidence, Stated Accurately

Neurofeedback and qEEG are separate questions, and conflating them does clients a disservice. The strongest evidence for neurofeedback is in ADHD. A systematic review and meta-analysis of sustained effects pooled ten randomized controlled trials covering 506 participants and found that neurofeedback outperformed non-active controls on inattention with a small effect at the end of treatment that grew to a medium effect at follow-up, and on hyperactivity and impulsivity with a small effect that also grew by follow-up.³

The comparison group is where precision matters. Neurofeedback significantly outperformed non-active control conditions on both symptom clusters, and its effects held or grew at follow-up. Measured against active treatment, primarily methylphenidate, the medication held a significant advantage on inattention at the end of treatment, and that advantage was no longer significant at follow-up.³ Superiority over a non-active control is a weaker claim than superiority over a sham condition, and the adequacy of blinding remains the live methodological argument in this field. A referring clinician can say honestly that there is meaningful evidence, that it is strongest in ADHD and that specialists continue to disagree about how much of the effect survives rigorous sham control.

Credentials Are the Most Useful Filter

Because the field is loosely regulated, the credential does more work here than in most referral decisions. Board certification in neurofeedback from the Biofeedback Certification International Alliance requires a bachelor’s degree or higher in an approved health care field, 36 hours of didactic neurofeedback education, 25 contact hours with an approved mentor, ten personal neurofeedback sessions, 100 patient treatment sessions, ten case study presentations and a proctored three-hour examination, with recertification every four years.⁴

That is a substantive floor, and it is checkable. Ask whether the person setting and adjusting the protocol holds the credential, not whether the practice employs someone who does. In many settings a certified clinician designs the protocol while an unlicensed technician runs the sessions, which is a defensible model if supervision is real and a problem if it is nominal.

Have the Cost Conversation Before You Refer

Given the coverage position described above, assume self-pay unless told otherwise. A qEEG assessment and a course of neurofeedback that may run 20 to 40 sessions is a significant commitment for an emerging adult or a family already paying for therapy and medication. Clients who learn the number at the first appointment often do not return, and the referring clinician absorbs the disappointment.

Ask the service for the qEEG cost, the per-session cost, the expected number of sessions and whether any portion is billed to insurance under a different code. Then say those numbers to the client before making the appointment.

Yellowbrick provides neuroscience technologies and neuromodulation services through an agreement with its sister company Synchrony Brain Health, whose outpatient services include neurofeedback alongside Deep TMS and cognitive enhancement. Credentialing, protocol design and cost structures differ between services, so confirm each of those directly rather than assuming they are standard across providers.

What to Verify Before You Refer

What to Tell the Client Before the First Appointment

• That qEEG guides the choice of training protocol and is not a stand-alone diagnostic test for their condition.
• That the evidence is strongest in ADHD and that specialists continue to disagree about parts of it.
• The likely total cost, including the assessment and the expected number of sessions.
• That most psychiatric qEEG and neurofeedback is self-pay, so they should not assume coverage.
• The expected time commitment, including session frequency and course length.
• That you intend to continue as their therapist and will receive summaries from the service.
• That a defined review point exists, and what happens if there is no response by then.
• That neurofeedback is being added to their current treatment rather than replacing it.
• Any relevant history you are sending, so the client is not surprised by what the service already knows.
• Who to contact at the service with questions between the referral and the first appointment.

Key Takeaway

Filter on three things: board certification in neurofeedback from the Biofeedback Certification International Alliance for whoever sets the protocol, a licensed clinician interpreting the qEEG rather than a software report and an itemized cost estimate before the first appointment. Keep qEEG and neurofeedback separate in your own explanation, since qEEG guides protocol selection and is treated as investigational for psychiatric diagnosis by both the long-standing professional position and current payer policy, while neurofeedback has meaningful evidence that is strongest in ADHD and clearest against non-active controls. Assume self-pay and say the number out loud before making the appointment. Where a client needs more than an outpatient course of training, programs providing assessment and graduated levels of care for this age range are the more appropriate first call.

Clinical Note

This article is general guidance for referring clinicians. It is not a substitute for individual clinical judgment or an individualized assessment, it does not establish suitability for any procedure and it does not constitute medical, coverage or benefits advice. Coverage policies vary by plan and change over time, professional positions on qEEG are contested and the evidence base for neurofeedback continues to develop. Confirm current coverage with the plan and current practice, credentials and costs directly with the service.

If a client is in immediate danger, direct them to emergency services. The 988 Suicide and Crisis Lifeline provides free, confidential crisis support 24 hours a day, seven days a week, by call or text to 988.⁵

Glossary

• Quantitative EEG (qEEG): computerized analysis of EEG recordings compared against normative databases, also described as brain mapping.
• Neurofeedback: operant training in which a person receives real-time feedback on brain activity with the aim of shifting it toward a target pattern.
• Protocol: the specific training parameters chosen for a client, including electrode placement and the frequency bands rewarded or inhibited.
• BCIA: the Biofeedback Certification International Alliance, which issues board certification in neurofeedback.
• Non-active control: a comparison condition involving no active intervention, which is a weaker comparator than a sham condition designed to be indistinguishable from treatment.
• Sham control: a comparison condition that mimics the appearance of treatment without its active component, used to control for expectation effects.
• Investigational: a designation indicating that evidence is considered insufficient to establish clinical usefulness for a stated purpose.

References

1. American Academy of Neurology and American Clinical Neurophysiology Society. “Assessment of Digital EEG, Quantitative EEG, and EEG Brain Mapping.” 1997. Accessed August 25, 2026. https://www.acns.org/pdf/guidelines/QEEG-Statement.pdf.
2. Aetna. “Quantitative EEG (Brain Mapping).” Clinical Policy Bulletin Number 0221, last reviewed April 14, 2026. Accessed August 25, 2026. https://www.aetna.com/cpb/medical/data/200_299/0221.html.
3. Van Doren J, Arns M, Heinrich H, Vollebregt MA, Strehl U, Loo SK. “Sustained effects of neurofeedback in ADHD: a systematic review and meta-analysis.” European Child and Adolescent Psychiatry, vol. 28, 2019, pages 293 to 305. Accessed August 25, 2026. https://link.springer.com/article/10.1007/s00787-018-1121-4.
4. Biofeedback Certification International Alliance. “Board Certification in Neurofeedback.” BCIA neurofeedback brochure. Accessed August 25, 2026. https://bcia.memberclicks.net/assets/NFCommonDocs/NF%20Brochure.pdf.
5. 988 Suicide and Crisis Lifeline. Operated in partnership with the Substance Abuse and Mental Health Services Administration and Vibrant Emotional Health. Accessed August 25, 2026. https://988lifeline.org/.

Learn more about Yellowbrick Consultation and Treatment Center on Google.